<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37932487</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3669</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>06</Day></PubDate></JournalIssue><Title>Communications chemistry</Title><ISOAbbreviation>Commun Chem</ISOAbbreviation></Journal><ArticleTitle>Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies.</ArticleTitle><Pagination><StartPage>241</StartPage><MedlinePgn>241</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">241</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42004-023-01043-9</ELocationID><Abstract><AbstractText>Cyclic-AMP-response element-binding protein (CREB) is a leucine zipper class transcription factor that is activated through phosphorylation. Ample CREB phosphorylation is required for neurotrophin expression, which is of key importance for preventing and regenerating neurological disorders, including the sequelae of long COVID syndrome. Here we created lipid-peptide nanoassemblies with different liquid crystalline structural organizations (cubosomes, hexosomes, and vesicles) as innovative nanomedicine delivery systems of bioactive PUFA-plasmalogens (vinyl ether phospholipids with polyunsaturated fatty acid chains) and a neurotrophic pituitary adenylate cyclase-activating polypeptide (PACAP). Considering that plasmalogen deficiency is a potentially causative factor for neurodegeneration, we examined the impact of nanoassemblies type and incubation time in an in vitro Parkinson's disease (PD) model as critical parameters for the induction of CREB phosphorylation. The determined kinetic changes in CREB, AKT, and ERK-protein phosphorylation reveal that non-lamellar PUFA-plasmalogen-loaded liquid crystalline lipid nanoparticles significantly prolong CREB activation in the neurodegeneration model, an effect unattainable with free drugs, and this effect can be further enhanced by the cell-penetrating peptide PACAP. Understanding the sustained CREB activation response to neurotrophic nanoassemblies might lead to more efficient use of nanomedicines in neuroregeneration.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CNRS, Institut Galien Paris-Saclay, F-91400, Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelov</LastName><ForeName>Borislav</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3131-4822</Identifier><AffiliationInfo><Affiliation>Extreme Light Infrastructure ERIC, CZ-25241, Dolni Brezany, Czech Republic. Borislav.Angelov@eli-beams.eu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yuru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Wenzhou Institute, University of Chinese Academy of Sciences, No.1, Jinlian Road, Longwan District, Wenzhou, Zhejiang, 325001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujino</LastName><ForeName>Takehiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Rheological Functions of Food, 2241-1 Kubara, Hisayama-cho, Kasuya-gun, Fukuoka, 811-2501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Md Shamim</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Institute of Rheological Functions of Food, 2241-1 Kubara, Hisayama-cho, Kasuya-gun, Fukuoka, 811-2501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drechsler</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7192-7821</Identifier><AffiliationInfo><Affiliation>Keylab "Electron and Optical Microscopy", Bavarian Polymerinstitute (BPI), University of Bayreuth, Universit&#xe4;tsstrasse 30, D-95440, Bayreuth, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelova</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0285-0637</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CNRS, Institut Galien Paris-Saclay, F-91400, Orsay, France. angelina.angelova@universite-paris-saclay.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CZ.02.1.01/0.0/0.0/15_003/0000447 (ELIBIO)</GrantID><Agency>EC | European Regional Development Fund (Europski Fond za Regionalni Razvoj)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Chem</MedlineTA><NlmUniqueID>101725670</NlmUniqueID><ISSNLinking>2399-3669</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>7</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>7</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37932487</ArticleId><ArticleId IdType="pmc">PMC10628290</ArticleId><ArticleId IdType="doi">10.1038/s42004-023-01043-9</ArticleId><ArticleId IdType="pii">10.1038/s42004-023-01043-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 2021;6:1078&#x2013;1094. doi: 10.1038/s41578-021-00358-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41578-021-00358-0</ArticleId><ArticleId IdType="pmc">PMC8353930</ArticleId><ArticleId IdType="pubmed">34394960</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai J, Fong C, Tran N, Drummond CJ. Non-lamellar lyotropic liquid crystalline lipid nanoparticles for the next generation of nanomedicine. ACS Nano. 2019;13:6178&#x2013;6206. doi: 10.1021/acsnano.8b07961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.8b07961</ArticleId><ArticleId IdType="pubmed">31082192</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong W-K, Negrini R, Vallooran JJ, Mezzenga R, Boyd BJ. Responsive self-assembled nanostructured lipid systems for drug delivery and diagnostics. J. Colloid Interface Sci. 2016;484:320&#x2013;339. doi: 10.1016/j.jcis.2016.08.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcis.2016.08.077</ArticleId><ArticleId IdType="pubmed">27623190</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova A, Angelov B, Mutafchieva R, Lesieur S, Couvreur P. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery. Acc. Chem. Res. 2011;44:147&#x2013;156. doi: 10.1021/ar100120v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ar100120v</ArticleId><ArticleId IdType="pubmed">21189042</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghmur A, Mu H. Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles. Acta Pharm. Sin. B. 2021;11:871&#x2013;885. doi: 10.1016/j.apsb.2021.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.02.013</ArticleId><ArticleId IdType="pmc">PMC8105777</ArticleId><ArticleId IdType="pubmed">33996404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai X, et al. A polytherapy based approach to combat antimicrobial resistance using cubosomes. Nat. Commun. 2022;13:343. doi: 10.1038/s41467-022-28012-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28012-5</ArticleId><ArticleId IdType="pmc">PMC8763928</ArticleId><ArticleId IdType="pubmed">35039508</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Angelova A. Coronavirus-induced host cubic membranes and lipid-related antiviral therapies: a focus on bioactive plasmalogens. Front. Cell Dev. Biol. 2021;9:630242. doi: 10.3389/fcell.2021.630242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.630242</ArticleId><ArticleId IdType="pmc">PMC8006408</ArticleId><ArticleId IdType="pubmed">33791293</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova A, Angelov B. Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair. Neural Regen. Res. 2017;12:886&#x2013;889. doi: 10.4103/1673-5374.208546.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.208546</ArticleId><ArticleId IdType="pmc">PMC5514857</ArticleId><ArticleId IdType="pubmed">28761415</ArticleId></ArticleIdList></Reference><Reference><Citation>Dully M, Ceresnakova M, Murray D, Soulimane T, Hudson SP. Lipid cubic systems for sustained and controlled delivery of antihistamine drugs. Mol. Pharm. 2021;18:3777&#x2013;3794. doi: 10.1021/acs.molpharmaceut.1c00279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.1c00279</ArticleId><ArticleId IdType="pmc">PMC8493555</ArticleId><ArticleId IdType="pubmed">34547899</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan S, Fong W-K, Kirby N, Hanley T, Boyd BJ. Evaluating the link between self-assembled mesophase structure and drug release. Int. J. Pharm. 2011;421:176&#x2013;182. doi: 10.1016/j.ijpharm.2011.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2011.09.022</ArticleId><ArticleId IdType="pubmed">21963475</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T-H, Hanley T, Porter CJH, Boyd BJ. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J. Controlled Release. 2011;153:180&#x2013;186. doi: 10.1016/j.jconrel.2011.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2011.03.033</ArticleId><ArticleId IdType="pubmed">21497623</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M, et al. Liquid crystalline lipid nanoparticles for combined delivery of curcumin, fish oil and BDNF: In vitro neuroprotective potential in a cellular model of tunicamycin-induced endoplasmic reticulum stress. Smart Mater. Med. 2022;3:274&#x2013;288. doi: 10.1016/j.smaim.2022.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smaim.2022.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu MN, Kelly HG, Kent SJ, Wheatley AK. Current and future nanoparticle vaccines for COVID-19. eBioMedicine. 2021;74:103699. doi: 10.1016/j.ebiom.2021.103699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103699</ArticleId><ArticleId IdType="pmc">PMC8602808</ArticleId><ArticleId IdType="pubmed">34801965</ArticleId></ArticleIdList></Reference><Reference><Citation>Dourado D, et al. Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials? Biomed. Pharmacother. 2021;139:111578. doi: 10.1016/j.biopha.2021.111578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111578</ArticleId><ArticleId IdType="pmc">PMC8023207</ArticleId><ArticleId IdType="pubmed">33848774</ArticleId></ArticleIdList></Reference><Reference><Citation>Valizadeh H, et al. Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int. Immunopharmacol. 2020;89:107088. doi: 10.1016/j.intimp.2020.107088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107088</ArticleId><ArticleId IdType="pmc">PMC7574843</ArticleId><ArticleId IdType="pubmed">33129099</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry Z, Klenja D, Janjua N, Cami-Kobeci G, Ahmed B. COVID-19 and Parkinson&#x2019;s Disease: shared inflammatory pathways under oxidative stress. Brain Sci. 2020;10:807. doi: 10.3390/brainsci10110807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10110807</ArticleId><ArticleId IdType="pmc">PMC7693814</ArticleId><ArticleId IdType="pubmed">33142819</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa C, Rivellini E, Lavitrano M, Combi R. Can SARS-CoV-2 infection exacerbate Alzheimer&#x2019;s Disease? An overview of shared risk factors and pathogenetic mechanisms. J. Pers. Med. 2022;12:29. doi: 10.3390/jpm12010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12010029</ArticleId><ArticleId IdType="pmc">PMC8780286</ArticleId><ArticleId IdType="pubmed">35055344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T, Crewther S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J. Neurol. Sci. 2020;419:117179. doi: 10.1016/j.jns.2020.117179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117179</ArticleId><ArticleId IdType="pmc">PMC7550857</ArticleId><ArticleId IdType="pubmed">33070003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, Chen C, Dong X-P. Impact of COVID-19 pandemic on patients with neurodegenerative diseases. Front. Aging Neurosci. 2021;13:664965. doi: 10.3389/fnagi.2021.664965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.664965</ArticleId><ArticleId IdType="pmc">PMC8060506</ArticleId><ArticleId IdType="pubmed">33897410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019;15:565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, et al. NIA&#x2010;AA research framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562. doi: 10.1016/j.jalz.2018.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Akanchise T, Angelova A. Potential of nano-antioxidants and nanomedicine for recovery from neurological disorders linked to long COVID syndrome. Antioxidants. 2023;12:393. doi: 10.3390/antiox12020393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12020393</ArticleId><ArticleId IdType="pmc">PMC9952277</ArticleId><ArticleId IdType="pubmed">36829952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O. Biomarkers for neurodegenerative diseases. Nat. Med. 2021;27:954&#x2013;963. doi: 10.1038/s41591-021-01382-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01382-x</ArticleId><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantamadiotis T, et al. Disruption of CREB function in brain leads to neurodegeneration. Nat. Genet. 2002;31:47&#x2013;54. doi: 10.1038/ng882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng882</ArticleId><ArticleId IdType="pubmed">11967539</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi H, Chang H-Y, Sang T-K. Neuronal cell death mechanisms in major neurodegenerative diseases. Int. J. Mol. Sci. 2018;19:3082. doi: 10.3390/ijms19103082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19103082</ArticleId><ArticleId IdType="pmc">PMC6213751</ArticleId><ArticleId IdType="pubmed">30304824</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenini G, Lloret A, Cascella R. Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxid. Med. Cell. Longev. 2019;2019:1&#x2013;18. doi: 10.1155/2019/2105607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2105607</ArticleId><ArticleId IdType="pmc">PMC6532273</ArticleId><ArticleId IdType="pubmed">31210837</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, Trojanowski JQ, Lee VM-Y. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 2020;16:199&#x2013;212. doi: 10.1038/s41582-020-0333-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0333-7</ArticleId><ArticleId IdType="pmc">PMC9242841</ArticleId><ArticleId IdType="pubmed">32203399</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F-C, Graybiel AM. Dopamine and calcium signal interactions in the developing striatum: control by kinetics of CREB phosphorylation. Adv. Pharmacol. 1997;42:682&#x2013;686. doi: 10.1016/S1054-3589(08)60840-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1054-3589(08)60840-6</ArticleId><ArticleId IdType="pubmed">9327991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MdS, Mawatari S, Fujino T. Plasmalogens, the vinyl ether-linked glycerophospholipids, enhance learning and memory by regulating brain-derived neurotrophic factor. Front. Cell Dev. Biol. 2022;10:828282. doi: 10.3389/fcell.2022.828282.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.828282</ArticleId><ArticleId IdType="pmc">PMC8864319</ArticleId><ArticleId IdType="pubmed">35223852</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman SU, et al. Neurological enhancement effects of melatonin against brain injury-induced oxidative stress, neuroinflammation, and neurodegeneration via AMPK/CREB signaling. Cells. 2019;8:760. doi: 10.3390/cells8070760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8070760</ArticleId><ArticleId IdType="pmc">PMC6678342</ArticleId><ArticleId IdType="pubmed">31330909</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid R-S, et al. NCAM stimulates the ras-MAPK pathway and CREB phosphorylation in neuronal cells. J. Neurobiol. 1999;38:542&#x2013;558. doi: 10.1002/(SICI)1097-4695(199903)38:4&lt;542::AID-NEU9&gt;3.0.CO;2-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4695(199903)38:4&lt;542::AID-NEU9&gt;3.0.CO;2-1</ArticleId><ArticleId IdType="pubmed">10084688</ArticleId></ArticleIdList></Reference><Reference><Citation>Espana J, et al. b-Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1. J. Neurosci. 2010;30:9402&#x2013;9410. doi: 10.1523/JNEUROSCI.2154-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2154-10.2010</ArticleId><ArticleId IdType="pmc">PMC6632424</ArticleId><ArticleId IdType="pubmed">20631169</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugazhenthi S, Wang M, Pham S, Sze C-I, Eckman CB. Downregulation of CREB expression in Alzheimer&#x2019;s brain and in ab-treated rat hippocampal neurons. Mol. Neurodegener. 2011;6:60. doi: 10.1186/1750-1326-6-60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-60</ArticleId><ArticleId IdType="pmc">PMC3174124</ArticleId><ArticleId IdType="pubmed">21854604</ArticleId></ArticleIdList></Reference><Reference><Citation>Namgyal D, Ali S, Mehta R, Sarwat M. The neuroprotective effect of curcumin against Cd-induced neurotoxicity and hippocampal neurogenesis promotion through CREB-BDNF signaling pathway. Toxicology. 2020;442:152542. doi: 10.1016/j.tox.2020.152542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2020.152542</ArticleId><ArticleId IdType="pubmed">32735850</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W-N, et al. Activation of WNT and CREB signaling pathways in human neuronal cells in response to the Omega-3 fatty acid docosahexaenoic acid (DHA) Mol. Cell. Neurosci. 2019;99:103386. doi: 10.1016/j.mcn.2019.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2019.06.006</ArticleId><ArticleId IdType="pmc">PMC7001743</ArticleId><ArticleId IdType="pubmed">31202891</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MS, Mawatari S, Fujino T. Plasmalogens inhibit neuroinflammation and promote cognitive function. Brain Res. Bull. 2023;192:56&#x2013;61. doi: 10.1016/j.brainresbull.2022.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2022.11.005</ArticleId><ArticleId IdType="pubmed">36347405</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujino T, et al. Effects of plasmalogen on patients with mild cognitive impairment: a randomized, placebo-controlled trial in Japan. J. Alzheimer&#x2019;s Dis. Parkinsonism. 2018;08:08&#x2013;419.</Citation></Reference><Reference><Citation>Che H, et al. EPA-enriched ethanolamine plasmalogen and EPA-enriched phosphatidylethanolamine enhance BDNF/TrkB/CREB signaling and inhibit neuronal apoptosis in vitro and in vivo. Food Funct. 2020;11:1729&#x2013;1739. doi: 10.1039/C9FO02323B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9FO02323B</ArticleId><ArticleId IdType="pubmed">32043504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MdS, et al. Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling. PLoS ONE. 2013;8:e83508. doi: 10.1371/journal.pone.0083508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083508</ArticleId><ArticleId IdType="pmc">PMC3869814</ArticleId><ArticleId IdType="pubmed">24376709</ArticleId></ArticleIdList></Reference><Reference><Citation>Maasz G, et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models. Dis. Model. Mech. 2017;10:127&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5312006</ArticleId><ArticleId IdType="pubmed">28067625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, et al. Therapeutic potential of PACAP for neurodegenerative diseases. Cell. Mol. Biol. Lett. 2015;20:265&#x2013;278. doi: 10.1515/cmble-2015-0008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cmble-2015-0008</ArticleId><ArticleId IdType="pubmed">26204407</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown D, Tamas A, Regl&#xf6;di D, Tizabi Y. PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson&#x2019;s Disease. J. Mol. Neurosci. 2013;50:600&#x2013;607. doi: 10.1007/s12031-013-0015-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-013-0015-7</ArticleId><ArticleId IdType="pmc">PMC3676705</ArticleId><ArticleId IdType="pubmed">23625270</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad Y, Prentice RN, Boyd BJ, Rizwan SB. Comparison of cubosomes and hexosomes for the delivery of phenytoin to the brain. J. Colloid Interface Sci. 2022;605:146&#x2013;154. doi: 10.1016/j.jcis.2021.07.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcis.2021.07.070</ArticleId><ArticleId IdType="pubmed">34311309</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizwan SB, Boyd BJ, Rades T, Hook S. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins. Expert Opin. Drug Deliv. 2010;7:1133&#x2013;1144. doi: 10.1517/17425247.2010.515584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425247.2010.515584</ArticleId><ArticleId IdType="pubmed">20858165</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M, et al. Composition-switchable liquid crystalline nanostructures as green formulations of curcumin and fish oil. ACS Sustain. Chem. Eng. 2021;9:14821&#x2013;14835. doi: 10.1021/acssuschemeng.1c04706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acssuschemeng.1c04706</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova A, Drechsler M, Garamus VM, Angelov B. Pep-lipid cubosomes and vesicles compartmentalized by micelles from self-assembly of multiple neuroprotective building blocks including a large peptide hormone PACAP-DHA. ChemNanoMat. 2019;5:1381&#x2013;1389. doi: 10.1002/cnma.201900468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cnma.201900468</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova A, et al. Plasmalogen-based liquid crystalline multiphase structures involving docosapentaenoyl derivatives inspired by biological cubic membranes. Front. Cell Dev. Biol. 2021;9:617984. doi: 10.3389/fcell.2021.617984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.617984</ArticleId><ArticleId IdType="pmc">PMC7905036</ArticleId><ArticleId IdType="pubmed">33644054</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober A. Classic toxin-induced animal models of Parkinson&#x2019;s disease: 6-OHDA and MPTP. Cell Tissue Res. 2004;318:215&#x2013;224. doi: 10.1007/s00441-004-0938-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-004-0938-y</ArticleId><ArticleId IdType="pubmed">15503155</ArticleId></ArticleIdList></Reference><Reference><Citation>Blandini F, Armentero M-T, Martignoni E. The 6-hydroxydopamine model: News from the past. Parkinsonism Relat. Disord. 2008;14:S124&#x2013;S129. doi: 10.1016/j.parkreldis.2008.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2008.04.015</ArticleId><ArticleId IdType="pubmed">18595767</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyett BP, Yu H, Strachan J, Drummond CJ, Conn CE. Fusion dynamics of cubosome nanocarriers with model cell membranes. Nat. Commun. 2019;10:4492. doi: 10.1038/s41467-019-12508-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12508-8</ArticleId><ArticleId IdType="pmc">PMC6776645</ArticleId><ArticleId IdType="pubmed">31582802</ArticleId></ArticleIdList></Reference><Reference><Citation>Azhari H, Younus M, Hook SM, Boyd BJ, Rizwan SB. Cubosomes enhance drug permeability across the blood&#x2013;brain barrier in zebrafish. Int. J. Pharm. 2021;600:120411. doi: 10.1016/j.ijpharm.2021.120411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2021.120411</ArticleId><ArticleId IdType="pubmed">33675926</ArticleId></ArticleIdList></Reference><Reference><Citation>Francia V, Reker-Smit C, Salvati A. Mechanisms of uptake and membrane curvature generation for the internalization of silica nanoparticles by cells. Nano Lett. 2022;22:3118&#x2013;3124. doi: 10.1021/acs.nanolett.2c00537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.2c00537</ArticleId><ArticleId IdType="pmc">PMC9011393</ArticleId><ArticleId IdType="pubmed">35377663</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson AC, et al. The effects of serum removal on gene expression and morphological plasticity markers in differentiated SH-SY5Y cells. Cell. Mol. Neurobiol. 2022;42:1829&#x2013;1839. doi: 10.1007/s10571-021-01062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-021-01062-x</ArticleId><ArticleId IdType="pmc">PMC9239930</ArticleId><ArticleId IdType="pubmed">33656634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipley MM, Mangold CA, Szpara ML. Differentiation of the SH-SY5Y human neuroblastoma cell line. J. Vis. Exp. 2016;108:53193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828168</ArticleId><ArticleId IdType="pubmed">26967710</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazaroff M, Qi Y, Chikaraishi DM. Differentiation of a catecholaminergic CNS cell line modifies tyrosine hydroxylase transcriptional regulation. J. Neurochem. 1998;71:51&#x2013;59. doi: 10.1046/j.1471-4159.1998.71010051.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.71010051.x</ArticleId><ArticleId IdType="pubmed">9648850</ArticleId></ArticleIdList></Reference><Reference><Citation>Daubner SC, Le T, Wang S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem. Biophys. 2011;508:1&#x2013;12. doi: 10.1016/j.abb.2010.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2010.12.017</ArticleId><ArticleId IdType="pmc">PMC3065393</ArticleId><ArticleId IdType="pubmed">21176768</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T, et al. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci. Lett. 2000;288:163&#x2013;166. doi: 10.1016/S0304-3940(00)01229-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(00)01229-5</ArticleId><ArticleId IdType="pubmed">10876086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin E, Cavanaugh JE, Leak RK, Perez RG, Zigmond MJ. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. J. Neurosci. Res. 2008;86:108&#x2013;117. doi: 10.1002/jnr.21478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21478</ArticleId><ArticleId IdType="pubmed">17847117</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamprecht R. CREB: a message to remember. Cell. Mol. Life Sci. 1999;55:554&#x2013;563. doi: 10.1007/s000180050314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000180050314</ArticleId><ArticleId IdType="pmc">PMC11146934</ArticleId><ArticleId IdType="pubmed">10357226</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch J, Kolch W, Laurent S, Mahmoudi M. Big signals from small particles: regulation of cell signaling pathways by nanoparticles. Chem. Rev. 2013;113:3391&#x2013;3406. doi: 10.1021/cr3002627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr3002627</ArticleId><ArticleId IdType="pubmed">23428231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazemidashtarjandi S, Vahedi A, Farnoud AM. Lipid chemical structure modulates the disruptive effects of nanomaterials on membrane models. Langmuir. 2020;36:4923&#x2013;4932. doi: 10.1021/acs.langmuir.0c00295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.langmuir.0c00295</ArticleId><ArticleId IdType="pmc">PMC8725912</ArticleId><ArticleId IdType="pubmed">32312045</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfredsson, V., Lo Nostro, P., Ninham, B. &amp; Nylander, T. Morphologies and structure of brain lipid membrane dispersions. Front. Cell Dev. Biol. 9, 675140 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236638</ArticleId><ArticleId IdType="pubmed">34195192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramalho MJ, Andrade S, Loureiro JA, do Carmo Pereira M. Nanotechnology to improve the Alzheimer&#x2019;s disease therapy with natural compounds. Drug Deliv. Transl. Res. 2020;10:380&#x2013;402. doi: 10.1007/s13346-019-00694-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13346-019-00694-3</ArticleId><ArticleId IdType="pubmed">31773421</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerzoni LPB, Nicolas V, Angelova A. In vitro modulation of TrkB receptor signaling upon sequential delivery of curcumin-DHA loaded carriers towards promoting neuronal survival. Pharm. Res. 2017;34:492&#x2013;505. doi: 10.1007/s11095-016-2080-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11095-016-2080-4</ArticleId><ArticleId IdType="pubmed">27995523</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MdS, Mineno K, Katafuchi T. Neuronal orphan G-protein coupled receptor proteins mediate plasmalogens-induced activation of ERK and Akt signaling. PLOS ONE. 2016;11:e0150846. doi: 10.1371/journal.pone.0150846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150846</ArticleId><ArticleId IdType="pmc">PMC4775022</ArticleId><ArticleId IdType="pubmed">26934370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, et al. Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association. Nat. Commun. 2022;13:2256. doi: 10.1038/s41467-022-29948-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29948-4</ArticleId><ArticleId IdType="pmc">PMC9042921</ArticleId><ArticleId IdType="pubmed">35474062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M, Angelov B, Garamus VM, Angelova A. Curcumin- and fish oil-loaded spongosome and cubosome nanoparticles with neuroprotective potential against H2O2-induced oxidative stress in differentiated human SH-SY5Y cells. ACS Omega. 2019;4:3061&#x2013;3073. doi: 10.1021/acsomega.8b03101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.8b03101</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>